Oncology

Your Article Summary

See Latest Articles

Ovarian cancer survival population differences: a high resolution study comparing Philippine residents, and Filipino-Americans and Caucasians living in the US
BMC Cancer, 09/29/09

Redanie MTM et al. – Multivariate analyses disclosed strong survival disadvantages of Philippine residents compared to Filipino-American patients, for which differences in access to health care might have played an important role. Survival is no worse among Filipino-Americans than among Caucasians living in the US.

• Databases from the SEER 13 and from the Manila and Rizal Cancer Registries
• Age-adjusted 5 y absolute and relative survival estimates were computed using the period analysis method and compared between Filipino-American ovarian cancer patients with cancer patients from the Philippines and Caucasians in the US
• Cox proportional hazards modelling used to determine factors affecting survival differences

• 5 y absolute and relative survival were lower in Philippine residents (Absolute survival, AS, 44%, Standard Error, SE, 2.9 and Relative survival, RS, 49.7%, SE, 3.7) than in Filipino-Americans (AS, 51.3%, SE, 3.1 and RS, 54.1%, SE, 3.4)
• After adjustment for these and additional covariates, strong excess risk of death for Philippine residents was found (Relative Risk, RR, 2.45, 95% confidence interval, 95% CI, 1.99-3.01)
• No significant differences found between Filipino-Americans and Caucasians living in US

Today in Gynecologic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Ovarian cancer screening and early detection
Women's Health, 11/04/09

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/06/09

See All of Gynecologic Oncology